RESMED INC
(RMD)CIK 943819 · SEC filings only
shown as history
Dividend record — shown as history, not graded
A declared dividend is a reported fact, not a promise we grade. Here's the record — raises, holds, and cuts — each linked to its source filing.
Dividend record
42 declarations · 12 raised · 29 held · 0 cut · held 41 quarters
- HELD$0.6000/shperiod ended 2026-03-31Filing ↗
- HELD$0.6000/shperiod ended 2025-12-31Filing ↗
- RAISED$0.6000/shperiod ended 2025-09-30Filing ↗
- HELD$0.5300/shperiod ended 2025-03-31Filing ↗
- HELD$0.5300/shperiod ended 2024-12-31Filing ↗
- RAISED$0.5300/shperiod ended 2024-09-30Filing ↗
- HELD$0.4800/shperiod ended 2024-03-31Filing ↗
- HELD$0.4800/shperiod ended 2023-12-31Filing ↗
- RAISED$0.4800/shperiod ended 2023-09-30Filing ↗
- HELD$0.4400/shperiod ended 2023-03-31Filing ↗
- HELD$0.4400/shperiod ended 2022-12-31Filing ↗
- RAISED$0.4400/shperiod ended 2022-09-30Filing ↗
harness minimum not met
Not enough resolved promises to grade
0 of the 4 resolved buyback promises needed to publish a reliability grade. Here's what we're tracking — we never show a grade we can't back with receipts.
buyback history
Free scorecards show the 12 most recent resolved buyback promises. See the complete multi-year record with Pro.
See Pro →Open promises (2)
Expects to resume its share repurchase program during upcoming quarter
Guiding to more than $1.85 billion in capital to be returned to shareholders through share repurchases and dividends during FY 2027
harness minimum not met
Not enough GAAP-comparable guidance to grade
0 of the 4 resolved guidance promises needed to publish a reliability grade. Much of this company’s guidance is non-GAAP, which has no comparable GAAP actual in SEC XBRL to check it against — shown below, never scored. Here's what we're tracking — we never show a grade we can't back with receipts.
guidance history
Free scorecards show the 12 most recent resolved guidance promises. See the complete multi-year record with Pro.
See Pro →Guidance shown, not graded (2)
These are non-GAAP forecasts. There is no comparable GAAP figure in SEC XBRL to check them against, so we show what was said — with its source filing — but never score it.
- eps guidance q · Jan 29, 2026mid-teens non-GAAP EPS growthUnverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Oct 24, 2024announced five-year revenue and earnings growth outlookUnverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
Open promises (3)
we are confident in our ability to grow steadily through our fiscal year 2022
we are confident in our ability to grow steadily throughout fiscal year 2023
announced five-year revenue and earnings growth outlook